Vinati Organics is engaged in manufacturing of speciality organic intermediates and monomers. IBB is the raw material for ibuprofen and Vinati is one of the largest global producer of IBB. The current installed capacity is 25,000 MTPA. It is number 1 manufacturer with a global market share of 65% as of FY20.
- Vinati Organics Ltd reported Total revenue for Q4 FY23 of ₹503 Crore, up from ₹486 Crore year on year depicting a growth of 3%.
- Total Expenses for Q4 FY23 of ₹351 Crore up, from ₹347 Crore year on year, a growth of 1%.
- Consolidated Net Profit of ₹115 Crore, up 14% from ₹101 Crore in the same quarter of the previous year.
- The Earnings per Share is ₹11.22, up 14% from ₹9.84 in the same quarter of the previous year.